(Q37719673)

22 August 2017

Treatment of mucocutaneous manifestations in Behçet's disease with anakinra: a pilot open-label study (English)

1 reference

22 August 2017

0 references

1 reference

4

H Nida Sen

1 reference

22 August 2017

Peter C Grayson

1

1 reference

22 August 2017

Yusuf Yazici

2

1 reference

22 August 2017

Melissa Merideth

3

1 reference

22 August 2017

Michael Davis

5

1 reference

22 August 2017

Elaine Novakovich

6

1 reference

22 August 2017

Elizabeth Joyal

7

1 reference

22 August 2017

Raphaela Goldbach-Mansky

8

1 reference

22 August 2017

Cailin H Sibley

9

1 reference

22 August 2017

24 March 2017

1 reference

Arthritis Research and Therapy

22 August 2017

1 reference

22 August 2017

19

1 reference

22 August 2017

1

1 reference

22 August 2017

69

1 reference

https://scigraph.springernature.com/pub.10.1186/s13075-017-1222-3

22 August 2017

0 references

cites work

Current Status, Goals, and Research Agenda for Outcome Measures Development in Behçet Syndrome: Report from OMERACT 2014.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5364674

Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5364674

Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5364674

EULAR recommendations for the management of Behçet disease

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5364674

A controlled trial of azathioprine in Behçet's syndrome

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5364674

Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5364674

Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5364674

Efficacy and safety profile of anti-interleukin-1 treatment in Behçet's disease: a multicenter retrospective study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5364674

Inhibition of interleukin-1 by canakinumab as a successful mono-drug strategy for the treatment of refractory Behçet's disease: a case series.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5364674

Development of the BD-QoL: a quality of life measure specific to Behçet's disease.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5364674

Behçet's disease: evaluation of a new instrument to measure clinical activity.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5364674

Apremilast for Behçet’s Syndrome — A Phase 2, Placebo-Controlled Study

1 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FS13075-017-1222-3

Anakinra treatment in drug-resistant Behcet’s disease: a case series

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FS13075-017-1222-3

Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28335798

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28335798

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Production of TNF-alpha and IL-1 in active Behçet's disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28335798

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/S13075-017-1222-3

1 reference

Dimensions Publication ID

22 August 2017

0 references

1 reference

22 August 2017

1 reference